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Abstract
Background: Although studies have shown that a large proportion of cancer patients use CAM, no study on CAM
use amongst orthopaedic oncology patients has been published. Therefore, this study aims to determine the
prevalence, characteristics and factors associated with CAM use amongst orthopaedic oncology patients.
Methods: All consecutive consenting patients/parents who presented at the Orthopaedic Oncology Clinic,
University Malaya Medical Centre (1st January to 31st December 2013) were interviewed using a structured
questionnaire.
Results: Overall, one hundred sixty-eight of the 274 patients recruited (61.3%) had used CAM at some time during
their current illness. The prevalence of CAM used was 68% (123/181) for patients with malignant tumours and
48.4% (45/93) for patients with benign tumours. The most popular CAMs were biological-based therapies (90.5%),
followed by mind-body techniques (40.5%). The most frequently used biological therapies were mega/multivitamins
(31%), snakehead (Chana striatus) (28%) and sea cucumber (Stichopus horrens) (18%); whereas prayers (31%) and
holy water (13%) dominated the mind-body category. Common reasons for CAM use were to improve physical
well-being (60.1%), try out everything that would help (59.5%) and to enhance wound-healing (39.3%). Independent
predictors for CAM use in multivariate analysis were paediatric patients [OR 2.46; 95% CI 0.99–6.06; p = 0.05], malignant
tumours [OR 1.90; 95% CI 1.12–3.25; p = 0.018] and patients who underwent surgery [OR 2.06; 95% CI 1.15–3.69; p = 0.015].
Majority patients started taking CAMs following suggestions from family members (53%) and friends (49%). Sixty-six
percent of patients felt they actually benefitted from CAM and 83.3% were satisfied/very satisfied. Only 5 patients reported
side-effects. Majority of CAM users planned to continue CAM use or recommend it to others. However, only 31.5% of
patients disclosed their CAM usage to their doctors.
Conclusions: This survey revealed a high prevalence of CAM usage amongst orthopaedic oncology patients, with
majority patients expressing satisfaction towards CAM. Oncologists should proactively ask patients about CAM to prevent
potential adverse effects, as most patients do not share this information with them.
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Background
The desire among human beings to explore beyond the
realms of conventional medical treatment is clearly illus-
trated by the usage of complementary and alternative
medicine (CAM) during illness [1,2]. This usage is more
pronounced when patients have difficult to treat chronic
medical ailments such as chronic pain, poor mental
health and cancer for which conventional medicine may
not provide effective and satisfactory remedies [1,2].
Cancer ranks amongst the most dreaded of all illness
[3]. As the diagnosis, symptoms and treatment of cancer
challenges every dimension of a person’s life including
physical, emotional, mental and spiritual aspects [3], pa-
tients with cancer are more receptive to CAM utilization.
CAM are defined as medical and healthcare systems, prac-
tices, and products that are not currently considered an
integral part of conventional medicine [4].
Many CAM users report use not so much as a result
of being dissatisfied with conventional medicine, but
largely because they found these healthcare alternatives
to be more congruent with their own values, beliefs, and
philosophical orientations toward health and life [1]. Al-
though the effectiveness and safety of certain CAM are
questionable, studies have reported widespread CAM
usage amongst cancer patients to increase body’s ability to
fight cancer, improve quality of life, strengthen immune
system and cope with disease symptoms [1,5-7]. Others
use CAM as a last resort and as a way of finding hope
[3,7,8]. Essentially, CAM meets the demands that main-
stream medicine cannot principally satisfy, and provides
complementary solutions to conventional medicine [9].
The increasing popularity of CAM amongst cancer pa-
tients is well recognized. A recent European survey re-
ported that the overall prevalence of CAM used by cancer
patients was 35.9%, ranging from 14.8% to 73.1% [5]. There
has been a noticeable increase in CAM usage amongst
cancer patients, from 25% in the 1970–1980s to 32% in the
1990s and 49% after 2000 [10]. As cancer incidence in-
creases and survival time lengthens, patients using CAM
are likely to escalate [7]. This trend is gradually recognized
by oncologists, although not many patients discuss these
therapies with them [7].
Evidence-based recommendations regarding the use-
fulness and safety or lack thereof of CAM practices in
oncology setting continues to evolve [11-17]. An increas-
ing number of evidence-based studies support the use of
CAM therapies as a complement to conventional cancer
therapies. For instance, Chinese medicinal herbs have
been shown to reduce treatment side-effects, improve
quality of life and survival rates amongst adult cancer
patients [11]. Hypnosis lessens pain, anxiety and distress
during procedures and appears to be especially effective
amongst paediatric cancer patients [12]. Medical Qigong
has been shown to improve quality of life, mood and
fatigue and reduces inflammation amongst cancer patients
[13]. Despite the growing scientific evidence favoring
CAM usage, numerous reports highlighting the adverse-
effects and risks to patient safety resulting from direct ef-
fect or possible interactions with conventional therapies
are emerging [14]. St John’s wort reduces plasma levels of
the active metabolites of three chemotherapy agents: iri-
notecan, imatinib mesylate, and docetaxel, with potential
deleterious consequences on treatment outcome [15]. Al-
though kava-containing products were found to be effect-
ive in controlling anxiety, stress and insomnia, recent
reports associate this herbal remedy with severe hepato-
toxicity [16]. Garlic, ginkgo, and ginseng, have been asso-
ciated with postoperative bleeding via platelet inhibitory
effects [17].
To date, numerous studies highlighting the growing use
of CAM amongst cancer patients have been reported.
These studies report either on patients with wide arrays of
cancers or focuses on specific cancer particularly breast,
prostate, gynecological and colorectal cancers [8]. However,
to our best knowledge, this study is the first to specifically
explore CAM usage amongst patients with orthopaedic on-
cology tumours. Another important distinction regarding
this study is that it involves patients of all age groups and
encompasses both malignant and benign tumours. This is
unlike most other studies that involve either adults or chil-
dren and focus solely on malignant tumours [6-8,10,18-20].
Advances in treatment in paediatric oncology field, have re-
sulted in an increase of 5-year survival rate of patients to
approximately 80% [21]. One important consequence of
this paradigm shift is that survivors of childhood cancer are
likely to encounter acute and long-term adverse-effects
resulting from the illness or mainstream medical therapies
[22]. This drives many parents and patients to use CAM to
manage disease symptoms, treatment side-effects and re-
peated painful operations despite the paucity of data sup-
porting their efficacy and safety [12,22].
Thus, an exhaustive coverage is integral towards under-
standing CAM usage amongst orthopaedic oncology pa-
tients, since this field comprises both malignant and
benign tumours and involves all age-groups. Therefore,
this study was conducted amongst patients with ortho-
paedic oncology tumours to determine: the prevalence,
characteristics, predictors and reasons for CAM use, types
of CAM therapies and practices used, satisfaction with
CAM, source of information and disclosure to doctors.
Methods
Study design, setting and study population
This was a prospective, cross-sectional study conducted
from 1st January to 31st December, 2013 at the
Orthopaedic Oncology Clinic, University Malaya Med-
ical Centre (UMMC), a 1051-bedded tertiary referral
centre situated in Kuala Lumpur. As the leading referral
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centre for orthopaedic oncology patients in Malaysia, its
patient population is reflective of a larger community in
Malaysia. The study was approved by the Medical Ethics
Committee of UMMC (Reference No: 944.12).
Patients with histologically confirmed bone and soft
tissue tumours, diagnosed for at least 2 months were re-
cruited consecutively as they presented to the clinic. In-
formed consent was obtained from patients or parents/
caregivers for patients < 18 years. Patients were excluded
if they were unable to give informed consent or if their
condition precluded the ability to do so.
Questionnaire
For questionnaire development, an extensive literature
search exploring CAM usage amongst cancer patients
was conducted. Pre-test of the questionnaire was under-
taken to obtain feedback from 6 orthopaedic oncology pa-
tients. Patients were asked to suggest CAMs not already
in the existing list. The pre-test feedback and information
captured from healthcare professionals, was used to de-
velop a culturally relevant and comprehensive question-
naire. Four interviewers were trained to administer the
questionnaires. To increase reliability and validity of re-
sponses, face-to-face interviews were conducted using
structured questionnaire.
The questionnaire comprised three main sections. The
first section captured basic socio-demographic data, such
as age, gender, religion, marital status, highest education
level and income. The second section captured disease-
related characteristics such as tumour type, presence of
metastasis, time since diagnosis and treatment. This infor-
mation was cross-checked with medical notes. Bone and
soft tissue tumours were classified according to World
Health Organization (WHO) classification [23].
Each patient was presented with a list of CAMs on the
questionnaire. These CAMs were broadly divided into 5
modalities based on National Centre for Complementary
and Alternative Medicine (NCCAM, 2005) and Cochrane
CAM Field categorization [24,25]. These were: biological,
spiritual/mind-body, alternative, physical (body-based)
and energy therapies. Patients were then asked if they had
used any of the listed CAMs or any other CAMs not
listed, either before or after their diagnosis. Patients were
considered CAM users if they had used CAM at least
once and non-users if they had not used any CAM during
the current illness. Patients who had been using CAM
even before their diagnosis were regarded non-users, un-
less a change in pattern of usage was demonstrated after
diagnosis, e.g. increased dose or frequency. The third sec-
tion of the questionnaire captured information on types of
CAMs, reasons for use, benefits attained, satisfaction,
source of information and disclosures to doctors. For paedi-
atric patients, the questionnaire was answered mainly
by their parents. Non-users were acknowledged after
completing the socio-demographic and clinical section
and their interview ended here.
Data was analysed using SPSS version 20.0, comparing
CAM users and non-users. Categorical variables were
compared using Fisher’s exact test or Chi-squared test
(p < 0.05). Variables associated with CAM usage in the
univariate analysis were entered into multivariate logistic
regression analysis. Where appropriate, CAM use was
compared in patients with malignant verses benign tu-
mours and in adult verses paediatric patients.
Results
Prevalence, clinical characteristics and socio-demographic
status
During the one year study period, 285 patients were inter-
viewed, with complete data obtained from 274 patients.
There were 181 (66.1%) patients who presented with ma-
lignant tumours and 93 (33.9%) with benign tumours. The
various bone and soft tissue tumours (WHO, 2013) [23]
are presented in Table 1. Mean age was 41.27 ± 20.53 years
(range 8 to 90 years).
Overall, 168 patients (61.3%) had used CAM at some
time during their current illness. The prevalence of CAM
used was 68% (123/181) for patients with malignant tu-
mours and 48.4% (45/93) for patients with benign tu-
mours. Overall, 75.2% patients underwent surgery, 26.6%
underwent chemotherapy and 18.6% radiotherapy. Major-
ity patients used CAM either concurrently with conven-
tional therapy (44%) or upon completion of conventional
treatment (44.6%); whereas 11.3% started CAM before
conventional therapy but stopped upon commencing con-
ventional treatment.
Predictors for using CAM
Factors associated with CAM usage in univariate analyses
(p < 0.05) (Table 2) were paediatric patients, malignant tu-
mours, metastasis, patients who underwent chemotherapy
and surgery. Multivariate analysis revealed that paediatric
patients (OR 2.46; 95% CI 0.99–6.06; p = 0.05), malignant
tumours (OR 1.90; 95% CI 1.12–3.25; p = 0.018) and sur-
gery (OR 2.06; 95% CI 1.15–3.69; p = 0.015) remained sig-
nificant predictors. CAM use was not affected by gender,
ethnicity, marital status, income, educational level and
employment status.
Reasons for using CAM
Overall, the most common reasons that drove patients
to utilize CAM were to enhance overall health and phys-
ical well-being (60.1%), to try out everything that would
help (59.5%) and to enhance wound healing (39.3%)
(Table 3). When analysed separately, patients with malig-
nant tumours cited the first two reasons more commonly
whereas enhancement of wound healing was more com-
mon amongst patients with benign tumours. Other reasons
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did not differ significantly between the two groups and in-
cluded controlling disease progression (32.1%), boosting
immune system (27.4%) and alleviating disease symptoms
and toxic effects of conventional therapy (26.2%).
We then compared the paediatric and adult oncology
patients to determine the CAM motivators, and noted
no significant differences (Table 3). Most parents indicated
that they wanted to do everything possible for their child
(60%) and to improve the child’s general-health (56%),
paralleling the main reasons cited amongst the adult pa-
tients. However, reasons like controlling disease progres-
sion, seeking a cure, boosting immune system, alleviating
side-effective of conventional therapy were notably higher
amongst the paediatric patients, although not statistically
significant. It was reassuring to note that only 4 patients
utilized CAM because they felt dissatisfied with conven-
tional therapy.
Types of CAM used
The most common CAM modalities used were biological-
based therapies (90.5%), followed by mind-body techniques
(40.5%) (Table 4). Patients with malignant tumours were
more likely to use biological-based therapies (p = 0.04).
Conversely, patients with benign tumours were more likely
to use physical-based therapies (0.002). Majority patients
(61.5%) had used 2 or more CAM modalities. When paedi-
atric and adult patients were compared (Table 4), biological
therapies were used with equal frequencies and were the
most commonly used CAMs amongst both the groups. In
contrast, alternative therapy usage was significantly higher
amongst the adults patients (p = 0.027). Although mind-
body and physical practices were notably higher in adult
patients, the difference was not statistically significant.
The various CAMs used within each modality are de-
tailed in Table 5. Most frequently used biological therap-
ies were mega/multivitamins (31%), snakehead (Chana
striatus) (28%), sea cucumber (Stichopus horrens) (18%),
herbal remedies (13%), fish oil (13%), fruits juices with
antioxidant properties (10%), spirulina (9%), and sabah
snake grass (Clinacanthus nutans) (7.7%). Mega/multivi-
tamins were used in combination with other CAMs in
all but one patient.
The most common mind-body techniques were prayers
(31%) and holy water (13%), whereas, various message
techniques (19.6%) dominated the physical therapy cat-
egory. After excluding prayer healing, the overall CAM
prevalence remained almost the same (60%), as almost all
patients used other CAM modalities alongside prayer
healing. Other popular CAM methods were acupuncture
(9.5%), traditional healers (5.4%) and various traditional
Chinese medicines (6%). The most common CAMs used
amongst the 206 patients who underwent surgery were
snakehead and multivitamins/megavitamins (21.36% each
respectively) followed by sea cucumber (9.7%).
Amongst the paediatric oncology patients, multi/mega-
vitamins were the most frequently used CAM (56%).
Other biological-based therapies commonly used amongst
children were spirulina (20%), freshwater eel (16%), and
antioxidant pills (16%). Mind-body medicine (28%) was
the second most common CAM modality used; (prayer/
faith healing, n = 5, holy water, n = 5 and traditional healer,
n = 1). On the contrary, various physical and energy ther-
apies seemed unpopular amongst paediatric oncology pa-
tients; only 4 patients used them (massage, n = 2, cupping,
n = 1, bioelectromagnetic therapy, n = 1). Conspicuously,
none of the alternative therapies were used by the paediat-
ric oncology patients; all 16 patients who used acupunc-
ture were adult patients.
Table 1 Histological diagnosis (WHO Classification, 2013)
[23] (n = 274)
Malignant tumours of Bone and Soft Tissue (N = 181)
Bone (n = 109)
Osteogenic tumoursa 37




Tumours of undefined neoplastic nature 1
Soft tissue (n = 72)
Undifferentiated/unclassified sarcoma 22
Adipocytic tumours 17
Tumors of uncertain differentiation 16
Fibroblastic/myofibroblastic tumors 8
Nerve sheath tumor 4
Smooth muscle tumors 3
Vascular tumors of soft tissue 1
Skeletal muscle tumors 1
Benign tumours of Bone and Soft Tissue (n = 93)
Bone (n = 55)
Osteoclastic giant cell rich tumors 36
Tumor of undefined neoplastic nature 10
Chondrogenic tumor 8
Osteogenic tumor 1
Soft tissue (n = 38)
Adipocytic tumor 13
Vascular tumor of soft tissue 9
Fibroblastic/Myofibroblastic tumor 5
Nerve sheath tumor 4
Fibrohistocytic tumor 3
Benign tumor of uncertain differentiation 4
aAll were osteosarcoma, b64.7% were Ewing sarcoma, cAll were chondrosarcoma.
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Satisfaction with CAM
Overall, majority of CAM users were very satisfied/satis-
fied (83.3%) with no significant differences in CAM satis-
faction rates between malignant and benign tumour group
(p = 0.1) In response to an open-ended question, 66% of
CAM users felt they actually experienced positive effects
which were feeling more energetic and stronger (45%), en-
hanced wound healing (22.5%), pain relief (18%), calmer
mind and better sleep (11.7%), tumour shrinkage (5.4%),
improved appetite (5.4%), fewer side-effects from chemo-
therapy (3.6%), internal cleansing and body detoxification
(3.6%) and suppression of disease progression (2.7%). Ma-
jority of CAM users (67%) planned to continue CAM use
or recommend it to others. Similarly, majority parents
(84%) were satisfied with CAM use and 64% felt that their
child had actually benefitted in some way.
Only 5 patients (4 adults and 1 child) experienced un-
wanted effects which were; enlargement of swelling after
traditional message (n = 2), facial swelling after consuming
Chinese medication (n = 1), heatiness after consuming
mushroom- based capsules (n = 1) and excessive coughing
after consuming sabah snake grass (n = 1). Only 3 patients
discontinue conventional medicine for CAM; the reasons
cited were cost, side-effects and fear of radiotherapy.
Source of information and disclosure
When asked how CAM modalities were selected, major-
ity indicated family members (53%) and friends (49%) as
their main source, followed by mass media/websites
(24%) and own-will (18.5%). Only 14.3% of CAM usage
was based on recommendations by healthcare personnel
(Table 6). When analysed separately, the only difference
Table 2 Predictors of CAM use
Variable All patients (N = 274) (%) Users of CAM N (%) Nonusers of CAM N (%) P OR 95% C1
Paediatric Yes 32 (11.7) 25 (78.1) 7 (21.9) 0.04 2.47 1.03–5.94
No 242 (88.3) 143 (59.1) 99 (40.9)
Age range <20 58 (21.2) 38 (65.5) 20 (34.5) 0.43
21–40 77 (28.1) 43 (55.8) 34 (44.2)
41–60 78 (28.5) 52 (66.7) 26 (33.8)
>60 61 (22.3) 35 (57.4) 26 (42.6)
Gender Male 129 (47.1) 73 (56.6) 56 (43.4) 0.13 1.46 0.89–2.38
Female 145 (52.9) 95 (65.5) 50 (34.5)
Race Malay 118 (43.1) 76 (64.4) 42 (35.6) 0.64
Chinese 109 (39.8) 65 (59.6) 44 (40.4)
Indians 47 (17.2) 27 (57.4) 20 (42.6)
Marital status* Married 163 (67.4) 101 (62.0) 62 (38.0) 0.19 1.44 0.83–2.47
Not married 79 (32.6) 42 (53.2) 37 (46.8)
Education* Primary/secondary 167 (69.0) 94 (56.3) 73 (43.7) 0.19 1.46 0.83–2.58
College/university 75 (31.0) 49 (65.3) 26 (34.7)
Job status* Employed 109 (45.0) 61 (56.0) 48 (44.0) 0.37 1.27 0.76–2.12
Unemployed 133 (55.0) 82 (61.7) 51 (38.3)
Income* Less than 1000 151 (62.4) 91 (60.3) 60 (39.7) 0.63 1.14 0.67–1.93
More than 1000 91 (37.6) 52 (57.1) 39 (42.9)
Presence of metastasis Yes 88 (32.1) 62 (70.5) 26 (29.5) 0.03 1.80 1.05–3.10
No 186 (67.9) 106 (57.0) 80 (43.0)
Malignancy Malignant 181 (66.1) 123 (68.0) 58 (32.0) 0.002 2.26 1.36–3.78
Benign 93 (33.9) 45 (48.4) 48 (51.6)
Chemotherapy Yes 73 (26.6) 55 (75.3) 18 (24.7) 0.004 2.38 1.31–4.34
No 201 (73.4) 113 (56.2) 88 (43.8)
Surgery Yes 206 (75.2) 137 (66.5) 69 (33.5) 0.002 2.37 1.36–4.14
No 68 (24.8) 31 (45.6) 37 (54.4)
Radiotheraphy Yes 51 (18.6) 35 (68.6) 16 (31.4) 0.24 1.48 0.77–2.83
No 233 (81.4) 133 (59.6) 90 (40.4)
N = 274 for all variables, except variables labelled * (N = 242) as variable* excludes paediatric patients.
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noted was that patients with benign tumour were more
likely to start CAM resulting from their own initiative.
Majority (68.5%) of CAM users did not discuss these
therapies with their doctors. The non-disclosure rates
were similar for patients with malignant verses benign
tumors (p = 0. 941) and for adult verses paediatric patients
(p = 1). The 3 most common reasons for non-disclosure
were; ‘felt it was unnecessary’ (42.6%), ‘doctors did not ask’
(35%) and ‘afraid to tell as doctor may not agree’ (10.6%).
For patients who did disclose, the doctors responded as
follows; remained neutral (51%), encouraged (35.8%) and
discouraged (13.2%) CAM use. Only 25.6% of patients
were proactively asked about their CAM usage by their
doctors.
Discussion
To our best knowledge, this study is the first to specifically
explore CAM usage amongst patients with orthopaedic
oncology tumours. Since there have been no other similar
studies, we related our findings to other comparable stud-
ies, depending on the context of discussion. The preva-
lence of CAM used amongst orthopaedic oncology patients
was high. Overall, 61.3% patients used at least one CAM
modality during their current illness. CAM usage was sig-
nificantly higher amongst patients with malignant tumours
compared with their benign tumours counterparts (68%
versus 48.4%, p = 0.002); concurring with a nationwide sur-
vey amongst Japanese cancer patients which displayed
higher CAM usage in malignant tumours compared with
benign tumours; albeit at lower rates (45% versus 26%)
[26].The rate of 68% noted amongst patients with ma-
lignant tumours was higher than the prevalence re-
ported from previous studies amongst cancer patients
[6,10,18,26-28]. In a large European survey [5], the
highest prevalence of CAM was in pancreatic (56.3%),
liver (55.6%), bone/spinal (54.5%) and brain cancer
Table 3 Reasons for CAM use amongst 168 CAM users
Reasons for using CAM All patients
(N = 168) (%)
Malignant
(N = 123) (%)
Benign
(N = 45) (%)
P1 Adults
(N = 143) (%)
Paediatric
(N = 25) (%)
P2
Enhance overall health/physical well-being 101 (60.1) 80 (65.0) 21 (46.7) 0.03 87 (60.8) 14 (56.0) 0.648
Trying everything that can help 100 (59.5) 79 (64.2) 21 (46.7) 0.04 85 (59.4) 15 (60.0) 0.958
Enhance wound healing 66 (39.3) 42 (34.1) 24 (53.3) 0.02 58 (40.6) 8 (32.0) 0.419
Control disease progression 54 (32.1) 39 (31.7) 15 (33.3) 0.84 44 (30.8) 10 (40.0) 0.362
Boost immune system to fight disease 46 (27.4) 36 (29.3) 10 (22.2) 0.36 37 (25.9) 9 (36.0) 0.295
Alleviate disease symptoms/toxic effect of
conventional therapy
44 (26.2) 29 (23.6) 15 (33.3) 0.2 36 (25.2) 8 (32.0) 0.474
Improve psychological well-being and finding hope 30 (17.9) 21 (17.1) 9 (20.0) 0.66 27 (18.9) 3 (12.0) 0.574
More compatible with own value/belief towards
life and health
26 (15.5) 22 (17.9) 4 (8.9) 0.15 24 (16.8) 2 (8.0) 0.374
Allow to relax and helps in sleep 24 (14.3) 20 (16.3) 4 (8.9) 0.23 20 (14.0) 4 (16.0) 0.76
Seeking a cure 23 (13.7) 17 (13.8) 6 (13.3) 0.94 19 (13.3) 4 (16.0) 0.753
Complementary effect to conventional medicine 21 (12.5) 15 (12.2) 6 (13.3) 0.84 16 (11.2) 5 (20.0) 0.207
More control over own treatment 15 (8.9) 11 (8.9) 4 (8.9) 1 12 (8.4) 3 (12.0) 0.471
Conventional treatment is too toxic 7 (4.2) 6 (4.9) 1 (2.2) 0.68 6 (4.2) 1 (4.0) 1
Dissatisfied with conventional medicine 4 (2.4) 3 (2.4) 1 (2.2) 1 4 (2.8) 0 1
Columns do not sum to 100% due to the option of multiple answers.
P1comparison of patients with malignant verses benign tumours.
P2comparison of adult verses paediatric patients.
Table 4 CAM modalities used amongst 168 CAM users
Modalities All patients
(N = 168) (%)
Malignant
(N = 123) (%)
Benign
(N = 45) (%)
P1 Adults
(N = 143) (%)
Paediatric
(N = 25) (%)
P2
Biological 152 (90.5) 115 (93.5) 37 (82.2) 0.04 130 (90.9) 22 (88.0) 0.710
Mind-body 68 (40.5) 47 (38.2) 21 (46.7) 0.32 61 (42.7) 7 (28.0) 0.168
Physical 36 (21.4) 19 (15.4) 17 (37.8) 0.002 33 (23.1) 3 (12.0) 0.213
Alternative 24 (14.3) 18 (14.6) 6 (13.3) 0.83 24 (16.8) 0 (0) 0.027
Energy 15 (8.9) 12 (9.8) 3 (6.7) 0.76 13 (9.1) 2 (8.0) 1
Columns do not sum to 100% due to the option of multiple answers.
P1comparison of patients with malignant verses benign tumours.
P2comparison of adult verses paediatric patients.
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(50%) patients. However, the number of bone/spinal
cancer patients was small (n = 22), representing 2.3% of
patients in this series.
Apart from malignant tumours, the other independent
predictors for CAM use were paediatric patients and pa-
tients who underwent surgery. A considerable propor-
tion of paediatric patients used CAM, with significantly
higher rates than adults (78% versus 59%, p = 0.04). Like-
wise, high CAM usage (84.5%) was noted in another
study involving Malaysian children with cancer [20]. In a
systematic review, CAM prevalence amongst children
with cancers ranged from 6% to 91% [19]. This has been
linked to lower survival perspective and fewer days since
relapse [29], suggesting that CAM therapies may act as
coping strategies for families in efforts to try everything
Table 5 Types of CAM used amongst 168 CAM users
CAM N %
Biological therapy
Vitamin and mineral supplements
Mega/multivitamins 52 31
Calcium suplements 12 7
Antioxidant pills 7 4.2
Herbal
Sea cucumber/gamat (Stichopus horrens) 30 18
Herbal remedies 22 13
Fruit juice with antioxidant properties 17 10
Spirulina (Arthrospira plantensis) 15 9
Belalai gajah/sabah snake grass (Clinacanthus nutans) 13 7.7
Other medicinal plant 9 5.4
Medicinal mushroom supplements 9 5.4
Aloe vera 8 4.8
Apricot seed 7 4.2
Ginseng 7 4.2
Evening primrose 6 3.6
Green tea 6 3.6
Habatus sauda seeds 6 3.6
Medicinal tea 5 3
Ginko biloba 5 3
Non-herbal
Snakehead/haruan (Chana striatus) 47 28
Fish oil 22 13
Porcupine quill powder/dates 8 4.8
Honey 6 3.6
Special water 5 3
Birds nest 5 3
Special diet 10 6
Physical therapy





Prayer/faith healing 52 31
Holy water/zam zam water 22 13
Traditional healers 9 5.4
Meditation 8 4.8
Yoga 4 2.4
Support group 4 2.4
Mental imagery 1 0.6
Table 5 Types of CAM used amongst 168 CAM users
(Continued)
Energy therapy
Bioelectromagnetic therapy 7 4.2
Qi Gong 3 1.8
Manual healing 2 1.2
Taichi 2 1.2
Reiki 1 0.6




Traditional Chinese medicine 10 6
Traditional Indian medicine 2 1.2
Homeopathy 2 1.2
Please note that some respondents reported use of more than one type of
CAM within a CAM category; thus, response values in this table will not
necessarily add up to the values presented in Table 4. Additionally, response
totals are thus greater than total participants.
Table 6 Source of information amongst 168 CAM users
Source Total
(N = 168) (%)
Malignant
(N = 123) (%)
Benign




89 (53.0) 61 (49.6) 28 (62.2) 0.15
From friends 82 (49.0) 63 (51.6) 19 (42.2) 0.28
From mass media/
websites
40 (24.0) 28 (23.0) 12 (26.7) 0.62
Your own free will 31 (18.5) 16 (13.0) 15 (33.3) 0.003
From health
personnel
24 (14.3) 18 (14.6) 6 (13.3) 0.83
From other patients 20 (12.0) 15 (12.3) 5 (11.1) 0.83
From CAM
practitioner
16 (9.5) 13 (10.6) 3 (6.7) 0.56
From your church/
religious group
5 (3.0) 3 (2.4) 2 (4.4) 0.61
Columns do not sum to 100% due to the option of multiple answers.
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possible to cure or alleviate the pain and distress in their
children. Although we did not determine the effects of
parenteral socio-demographic and education characteris-
tics on CAM practices in children, no such influence
was found in another study involving Malaysia children
with cancer [20]. Children whose parents used CAM were
more likely to use CAM compared to children whose par-
ents did not [30]; this is not unexpected since children are
dependent on their parents for their healthcare decisions.
Concurring with another study [7], patients who under-
went surgery for tumour removal were more likely to use
CAM, particularly various biological modalities. This find-
ing should not be underestimated, as clinical complica-
tions during perioperative period can result from natural
therapies, either from direct effect or herb-drug inter-
action [17]. Thus, patients scheduled for surgery should
be questioned about none prescription medications usage
[17]. In retrospect, we should have added a question re-
garding CAM timing in relation to the surgery.
Patients with metastasis and those who received chemo-
therapy were more likely to use CAM, although these fac-
tors were not predictive in multivariate analysis. While
some studies reveal higher CAM usage amongst patients
with metastatic cancers [18], others suggest no association
with advanced disease [7,20]. Stage of disease impacted
patients’ reasons and expectations for CAM usage, al-
though it may not predict CAM use [7]. Although higher
education and socio-economic status have been linked to
CAM usage [1,5,8,18]; concurring with other studies we
found no such association [7]. Reasons that catalyze CAM
use in countries with higher socio-economic status, might
work in opposite directions in lower socio-economic sta-
tus countries [8]; the latter attributed to cultural factors
and more traditional lifestyle.
It is important for doctors to recognize the reasons mo-
tivating patients’ CAM usage. Our patients were mainly
motivated by the desire to try out everything possible to
fight the disease, to improve their general health and to
enhance wound healing. The first two reasons emerged at
significantly higher rates in patients with malignant com-
pared with benign tumours, suggesting that these patients
may be turning to CAMs as additional measures to en-
hance general overall health, rather than focusing solely on
their illness; supporting the philosophical congruence the-
ory [1]. CAM use was also fuelled by the desire to control
disease progression, boost the immune system and to cope
with treatment and/or its side-effects. Reassuringly, only 4
patients attributed dissatisfaction with conventional medi-
cine as a reason for using CAM. Our findings indicate that
patients are not deserting conventional therapies which
have been thoroughly tested, for unconventional treatment
which lack scientific evidence regarding safety and efficacy.
Due to the physical and psychological impacts of an
oncology condition, coping strategies are essential tools
for patients and parents to move through the illness tra-
jectory. Both biological therapies and mind-body tech-
niques were most frequently used amongst our patients
and its use may be explained by Lazarus and Folkmans’
problem-focused and emotion-focused coping strategies
[31,32]. Problem-focused strategies include the use of
various biological therapies in attempts to alleviate disease-
related symptoms or adverse-effects of conventional treat-
ment, while prayers and meditation techniques are
examples of emotional-focused coping strategies as pa-
tients venture into a spiritual and emotional journey
[18]. Factors that drive patients and parents towards the
uptake of CAM may also be viewed from a problem-
focused verses emotion –focused perspective. Overall,
when the factors motivating CAM usage were analysed,
they were skewed towards problem-focused factors (>20%
frequency each); these included enhancing physical well-
being, accelerating wound-healing, controlling disease
progression, boosting immune system and ameliorating
symptoms resulting from disease and treatment. Parents
of paediatric oncology patients also seemed lop-sided to-
wards problem-focused factors. During conventional
treatment, parents often play a passive role with little op-
portunity for active involvement in the healing process of
their children [33]. Coping strategies focusing on problem-
solving are action-centred and enables more involvement
in care activities of their child [33]. Other reasons such as
improving psychological well-being and finding hope, tak-
ing more control over own treatment, allowing to relax/
sleep may be described as emotion-focused factors and
were less frequently mentioned (<20% frequency) in our
study.
Majority of our patients were satisfied with CAM usage
and would continue its use and even recommend to others.
We believe that the satisfaction shown was because the ex-
pectations for CAM were met. Majority of our patients
took CAM with the hope of enhancing their physical well-
being and healing process, whilst only a small proportion
took CAM with the intention to cure their illness. This
mirrors the reasons for taking CAM and the resulting sat-
isfaction amongst Singaporean cancer patients [27]. Con-
versely, disappointment towards CAM was high amongst
Nigerian cancer patients, as majority used CAM to treat or
cure cancer, with unmet expectation ultimately [34].
Biological-based therapies were the most common
CAM used, with vitamins, snakehead and sea cucumber,
constituting the three most common biological therap-
ies. Vitamins were widely used in multiple series [5,7,27],
reflecting self-promoting behaviour contributing to gen-
eral health. A substantial proportion of our patients
embarked on various prayer healing methods and almost
all patients used these techniques alongside other CAM
modalities. Prayers and spiritual therapies are important
aspects amongst Malaysian oncology patients [35] and
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strong connections between reliance on religious beliefs
and the ability to cope with cancer has been shown [3],
contributing to psychosocial adjustment to cancer and its
treatment.
While the variances of what constitutes CAM possibly
contribute to the diverse prevalence rates reported in lit-
erature, we believe the multi-ethnicity of our patients with
its diverse cultural background, religious beliefs and prac-
tices contribute to the high prevalence and differential
patterns of CAM use. Worldwide these practices differ de-
pending on cultural habits, geographic locations, ethnic
backgrounds and religious beliefs. Majority of Japanese
cancer patients used products such as mushrooms, herbs
and shark cartilage [26], whereas spiritual practices and vi-
tamins which were widespread in our study and Western
countries [7] were rarely used amongst the Japanese can-
cer population [26]. Singapore cancer patients commonly
used traditional Chinese medicine, bird’s nest and special
diets [27], whereas in Turkey, herbal therapies such as
stinging nettle were used widely [28]. While spiritual ap-
proaches, vitamins and herbs were the most common
CAMs used in USA [7], Australian cancer patients used
mainly dietary supplements, prayers, herbs and relaxation
techniques/meditation [18]. Generally, natural products
are widely used amongst cancer patients emphasizing an
appeal for ‘natural’ remedies, as many patients believe nat-
ural equates to safe.
While energy, alternative and mind-body medicine had
similar usage across patients with benign and malignant
tumor, biological therapies were more common amongst
patients with malignant tumors. Contrariwise, physical
therapies involving various massage therapies were more
common amongst patients with benign tumor. Although
massage therapies alleviate anxiety and distress symptoms
amongst cancer patients, rare complications such as hae-
morrhage and fractures can occur [36], especially with
pre-existing weakened bone from underlying pathologies.
Acupuncture used by 10% of our patients, has been shown
to relieve cancer related pain and chemotherapy induced
nausea and vomiting [37]. However, it should be used cau-
tiously in patients with deranged clotting mechanisms e.g.
with impaired liver function, as bleeding can occur [37].
Only 2.4% of our patients used support groups, suggesting
a lack of support group amongst patients with musculo-
skeletal tumours.
Children are more likely to use biologically-based ther-
apies and mind-body therapies compared with alternative
or energy therapies [30], concurring with the findings of
our study. In a study conducted amongst children and ad-
olescents with cancer, adolescents showed a tendency to-
wards using more invasive therapies (e.g., acupuncture)
compared to children [38].
Majority of the patients seemed to detach CAM and
conventional medicine by not disclosing CAM use to
their doctors, with most patients having the perception
that disclosure was unnecessary. Disclosure rates of 20%
to 77% have been reported [39] and the main reasons
for non-disclosure were doctor’s lack of inquiry; patient’s
anticipation of the doctor’s disapproval, disinterest, or
inability to help and patient’s perception that CAM dis-
closure is irrelevant to conventional care [39].
Our study supports the role of family members and
friends on patient’s CAM uptake. Significant others (SOs)
such as family members, partners and close friends influ-
ence decisions about CAM use amongst cancer patients,
often acting as information providers and active decision
makers [40,41]. Qualitative studies also indicate the import-
ance of a supportive social network and the involvement of
SOs in uptake and maintenance of CAM, contributing to
bonding between patients and their SOs [41].
Many patients relied on information from unscientific
sources, such as mass media and internet. However,
these patients may be at risk of adverse effects as many
websites promote CAM without scientifically proven
safety and efficacy data [42]. Only 14.3% of our patients
received information regarding CAM from healthcare
professionals. This may be due to the fact that most
healthcare professionals feel they lack adequate know-
ledge or were not up-to-date with the best evidence on
CAM use in oncology [43].
Few limitations of this study must be acknowledged.
The drawback of face-to-face compared to anonymous
questionnaire is that participants may not disclose certain
information for fear of negative repercussions. However,
face-to-face interview allows respondents and interviewers
to seek clarification, increasing the response rates and reli-
ability of answers. Secondly, although we did attempt to
provide an exhaustive list of CAMs to ensure consistency
in defining CAMs and to reduce recall bias; participants
might still have been less likely to report the non-listed
CAMs. Although this study was confined to a single insti-
tution, being one of the main orthopaedic oncology refer-
ral centre in this country, it receives majority of referrals
in this region. Thus, this study could be taken as a proxy
indicator for CAM usage amongst orthopaedic oncology
patients.
Conclusions
This study highlights a high prevalence of CAM usage
amongst orthopaedic oncology patients, especially amongst
patients with malignant tumors, paediatric patients and pa-
tients who undergo surgery. Patients appear to use CAM in
conjunction with, not instead of conventional medicine.
Biological-based therapies were the most popular CAM
therapies used. Majority patients used CAM with the hope
of enhancing their physical well-being and healing process
and were generally satisfied with the CAMs. Given the high
prevalence of CAM usage amongst orthopaedic oncology
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patients, oncologists should proactively ask their patients
about CAM usage as most patients do not voluntarily dis-
close this information. In order to foster better patient-
doctor communication, oncologists should be familiar with
the commonly used CAM amongst patients, or at least be
able to direct them to reliable sources of information.
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